1. Market Health The (Re)New(ed) Ethics of Utilization IPR and The Role of the University in the Knowledge Economy Bowman Heiden CIP – Center for Intellectual Property University of Gothenburg Chalmers University of Technology bowman.heiden@gu.se

2. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme The University in the Knowledge Economy In 2007, Prof. Ulf Petrusson published a book together with Vinnova, the Swedish Innovation Agency, entitled The University in the Knowledge Economy in relation to the governmental review to change legislation regarding ownership of research results originating from public funding.

3. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme Research and Innovation In 2012, Prof. Ulf Petrusson published a book together the Swedish Finance Ministry entitled Research and Innovation – state governance of collaboration and utilization activities in higher education in relation to the change in legislation mandating that universities take on the formal responsibility to manage utilization activities.

4. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme ”I think you should be more explicit here in step two”

5. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme Knowledge Management Platform A system to support the utilization of university research

6. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme Public domain Innovation process Applicable to specific stakeholders Contractual network The academic environment operates to make knowledge available in open contractual structures/networks The academic environment operates to make knowledge available as products and knowledge organizations The academic environment operates to make knowledge available/applicable to specific stakeholders The academic environment operates to make knowledge available to the public Assets are managed as portfolios of background and foreground research results in contract-based knowledge platforms Assets are packaged as controlled ideas, which can be further developed as innovations. Assets are managed as applicable research results – which may require patentability or other types of control Assets are transferred to the public domain without any intellectual property right restrictions Utilization Logics

7. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme ? ? How can we define knowledge that is diffuse and difficult to communicate… …and create a clear basis for decisions involving the knowledge and results generated in the research? CHALLENGE HOW DO WE MANAGE KNOWLEDGE? !

8. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme Managing research results as intellectual assets

9. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme IA Capture Process

10. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme IA Positioning

11. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme DECISION MAKING ANALYZING INTELLECTUAL ASSETS We can analyze how assets can create value based on a number of parameters: 1.What is the potential to create value in different contexts? 2.How well do we control the asset?

12. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme IAM as means to make strategic decisions Further development What technology is lacking? What should be further developed in-house? What to buy/license from others? Venture creation What rights do we need to exploit the technology? What people and organizational activities do we need? Patenting/IPRs What should be patented? What other governance mechanisms are needed to protect our resources? What should be done regarding others’ IPRs? Collaboration Where do we need strategic partnerships? What of the things we bring to the table are valuable? What can be discussed freely/what is secret? Business modeling What is our unique technology and what utilities does it create? Is there a need for it? What could we offer to others? How could it be packaged?

13. The project is supported by the European Commission under the HEALTH thematic area of the 7th Research Framework Programme Session Participants  David Pardoe, Head of Growth Projects, MRC (Medical Research Council) Technologies, United Kingdom  Morris Berrie, Co- Founder TTS Global Initiative, United Kingdom  Peter Heydebreck, Deputy Chairman, innoveas international, United Kingdom  Olivier Lescroart, IP Officer, KU Leuven Research and Development, Belgium  Niclas Lundh, Senior Officer for Research and External Relations, Sahlgrenska Academy, University of Gothenburg, Sweden